Filing Details

Accession Number:
0001415889-21-002569
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-19 17:56:20
Reporting Period:
2021-05-17
Accepted Time:
2021-05-19 17:56:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1411906 Ampio Pharmaceuticals Inc. AMPE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277543 Dan Stokely C/O Ampio Pharmaceuticals, Inc.
373 Inverness Parkway, Suite 200
Englewood CO 80112
Cfo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-17 35,000 $0.43 63,315 No 4 M Direct
Common Stock Disposition 2021-05-18 35,000 $1.83 28,315 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-05-17 35,000 $0.00 35,000 $0.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
283,000 2029-08-20 No 4 M Direct
Footnotes
  1. Options were previously reported on a Form 4 dated August 22, 2019, where 50% of the stock option award vested and became exercisable on the date of grant, and the remaining 50% of the stock option award vested and became exercisable on July 31, 2020.